Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival

Rituraj Upadhyaya Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Aastha Dhakalb The Ohio State University College of Medicine, Columbus, OH, USAView further author information

Caroline Wheelerc Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Rebecca Hoydc Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Malvenderjit Jagjit Singhc Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Vidhya Kariveduc Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Priyanka Bhatejac Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Marcelo Bonomic Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Sasha Valentind Department of Dentistry, The Ohio State University Wexner Medical Center, Columbus, OH, USAView further author information

Mauricio E. Gameze Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USAView further author information

David J. Konieczkowskia Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Sujith Baligaa Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

John C. Greculaa Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Dukagjin M. Blakaja Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Emile Goginenia Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Darrion L. Mitchella Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Nicholas C. Denkoa Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAView further author information

Daniel Spakowiczc Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;f Pelotonia Institute for Immuno-Oncology, Columbus, OH, USAView further author information

Sachin R. Jhawara Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USACorrespondence[email protected]